Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linping Chen-Wichmann

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Haematologica|August 10, 2014
The truncated RUNX1/ETO activates VLA-4-dependent adhesion and migration of hematopoietic progenitor cellsKanagaraju Ponnusamy, Linping Chen-Wichmann, Olga N Kuvardina, et al.
Frontiers in Genetics|December 19, 2013
Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem/progenitor cellsFarnaz Faridi, Kanagaraju Ponnusamy, Isabell Quagliano-Lo Coco, et al.
Cancers|March 8, 2019
Oncogenic Deregulation of Cell Adhesion Molecules in LeukemiaRoland Windisch, Nina Pirschtat, Christian Kellner, et al.
Blood|May 1, 2010
Dimer-tetramer transition controls RUNX1/ETO leukemogenic activityChristian Wichmann, Yvonne Becker, Linping Chen-Wichmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|April 8, 2024
Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis SetsStefani Xhaxho, Linping Chen-Wichmann, Sophie Kreissig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2012
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicingKerstin B Kaufmann, Christian Brendel, Julia D Suerth, et al.
Human Gene Therapy Methods|March 16, 2013
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapyChristian Brendel, Walther Hänseler, Vital Wohlgensinger, et al.
Oncogene|August 11, 2018
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansionLinping Chen-Wichmann, Marina Shvartsman, Caro Preiss, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2026
Dual inhibition of PP2A and WEE1 induces apoptosis and mitotic catastrophe in cancer cellsAl-Hassan M Mustafa, Alexandra Nguyen, Sophie Kreissig, et al.
Experimental Hematology|February 19, 2022
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiationEnric Redondo Monte, Georg Leubolt, Roland Windisch, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Haematologica|August 10, 2014
The truncated RUNX1/ETO activates VLA-4-dependent adhesion and migration of hematopoietic progenitor cellsKanagaraju Ponnusamy, Linping Chen-Wichmann, Olga N Kuvardina, et al.
Frontiers in Genetics|December 19, 2013
Aberrant epigenetic regulators control expansion of human CD34+ hematopoietic stem/progenitor cellsFarnaz Faridi, Kanagaraju Ponnusamy, Isabell Quagliano-Lo Coco, et al.
Cancers|March 8, 2019
Oncogenic Deregulation of Cell Adhesion Molecules in LeukemiaRoland Windisch, Nina Pirschtat, Christian Kellner, et al.
Blood|May 1, 2010
Dimer-tetramer transition controls RUNX1/ETO leukemogenic activityChristian Wichmann, Yvonne Becker, Linping Chen-Wichmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|April 8, 2024
Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis SetsStefani Xhaxho, Linping Chen-Wichmann, Sophie Kreissig, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 5, 2012
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicingKerstin B Kaufmann, Christian Brendel, Julia D Suerth, et al.
Human Gene Therapy Methods|March 16, 2013
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapyChristian Brendel, Walther Hänseler, Vital Wohlgensinger, et al.
Oncogene|August 11, 2018
Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansionLinping Chen-Wichmann, Marina Shvartsman, Caro Preiss, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 9, 2026
Dual inhibition of PP2A and WEE1 induces apoptosis and mitotic catastrophe in cancer cellsAl-Hassan M Mustafa, Alexandra Nguyen, Sophie Kreissig, et al.
Experimental Hematology|February 19, 2022
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiationEnric Redondo Monte, Georg Leubolt, Roland Windisch, et al.
Pageof 2